Keller ET - Search Results

1

Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.

Loberg RD, Logothetis CJ, Keller ET, Pienta KJ. Loberg RD, et al. Among authors: keller et. J Clin Oncol. 2005 Nov 10;23(32):8232-41. doi: 10.1200/JCO.2005.03.0841. J Clin Oncol. 2005. PMID: 16278478 Review.

2

Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor".

Muenchen HJ, Lin DL, Walsh MA, Keller ET, Pienta KJ. Muenchen HJ, et al. Among authors: keller et. Clin Cancer Res. 2000 May;6(5):1969-77. Clin Cancer Res. 2000. Retraction in: Clin Cancer Res. 2002 Dec;8(12):3961. PMID: 10815922 Retracted.

3

Interleukin-6 and prostate cancer progression.

Smith PC, Hobisch A, Lin DL, Culig Z, Keller ET. Smith PC, et al. Among authors: keller et. Cytokine Growth Factor Rev. 2001 Mar;12(1):33-40. doi: 10.1016/s1359-6101(00)00021-6. Cytokine Growth Factor Rev. 2001. PMID: 11312117 Review.

4

Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.

Lin DL, Tarnowski CP, Zhang J, Dai J, Rohn E, Patel AH, Morris MD, Keller ET. Lin DL, et al. Among authors: keller et. Prostate. 2001 May 15;47(3):212-21. doi: 10.1002/pros.1065. Prostate. 2001. PMID: 11351351 Free article.

5

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.

Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET. Zhang J, et al. Among authors: keller et. J Clin Invest. 2001 May;107(10):1235-44. doi: 10.1172/JCI11685. J Clin Invest. 2001. PMID: 11375413 Free PMC article.

6

Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression.

Lin DL, Whitney MC, Yao Z, Keller ET. Lin DL, et al. Among authors: keller et. Clin Cancer Res. 2001 Jun;7(6):1773-81. Clin Cancer Res. 2001. PMID: 11410519

7

Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.

Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK. Taichman RS, et al. Among authors: keller et. Cancer Res. 2002 Mar 15;62(6):1832-7. Cancer Res. 2002. PMID: 11912162

8

Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells.

Fu Z, Dozmorov IM, Keller ET. Fu Z, et al. Among authors: keller et. Prostate. 2002 Apr 1;51(1):10-20. doi: 10.1002/pros.10056. Prostate. 2002. PMID: 11920953 Free article.

9

Prostate carcinoma skeletal metastases: cross-talk between tumor and bone.

Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS. Keller ET, et al. Cancer Metastasis Rev. 2001;20(3-4):333-49. doi: 10.1023/a:1015599831232. Cancer Metastasis Rev. 2001. PMID: 12085970 Free article. Review.

10

Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice.

Zhang J, Dai J, Lin DL, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Zhang J, et al. Among authors: keller et. J Bone Miner Res. 2002 Jul;17(7):1256-63. doi: 10.1359/jbmr.2002.17.7.1256. J Bone Miner Res. 2002. PMID: 12096839 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

247 results

Search Page

Filters